Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe

Authors
Lamarca, Angela
Morfouace, M.
Tejpar, S.
Oliveira, J.
Capela, A.
Penel, N.
Gennigens, C.
Brasiuniene, B.
Peron, J.
Stevovic, A.
Affiliation
Department of Oncology-OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid Spain; Department of Medical Oncology, The Christie NHS Foundation, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester
Issue Date
2022

Metadata
Show full item record
Abstract
None
Citation
Lamarca A, Morfouace M, Tejpar S, Oliveira J, Capela A, Penel N, et al. Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe. Annals of Oncology. 2022 Nov;33(11):1200-2. PubMed PMID: WOS:000883334100011.
Journal
Annals of Oncology
URI
http://hdl.handle.net/10541/625912
DOI
10.1016/j.annonc.2022.07.006.
PubMed ID
35926814
Additional Links
https://dx.doi.org/10.1016/j.annonc.2022.07.006.
Type
Article
Language
en
Collections